Skip to content
AnalystLens
Back to HALOBalance Sheet

Halozyme Therapeutics Shares Outstanding 2010-2026 | HALO

Annual FY2010–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

117.8M

−4.3%YoY vs FY2024Source: 10-KFY2025

From 100.6M in FY2010 to 117.8M in FY2025: 1.2× in 15 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26119M−3.8%114M−3.0%114M−3.1%Not reported
FY25123M−3.2%118M−7.0%118M−7.6%118M−4.3%
FY24127M−3.4%127M−4.0%127M−3.7%123M−2.9%
FY23132M−4.5%132M−4.2%132M−2.3%127M−6.2%
FY22138M−3.8%138M−3.2%135M−4.1%135M−1.7%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionDeclining
CAGR

−2.7%

FY2020
135.0M
FY2025
117.8M

5 years selected · on the chart

Shares Outstanding History

Year-over-year comparison from 10-K annual reports

  1. 117.8M
YoY changeLargest recent move+10.3%in FY17Latest −4.3%

Shares Outstanding, period by period

PeriodValueChangeSource
FY2025117.8M−4.3%10-K
FY2024123.1M−2.9%10-K
FY2023126.8M−6.2%10-K
FY2022135.2M−1.7%10-K
FY2021137.5M+1.8%10-K
FY2020135.0M−1.2%10-K
FY2019136.7M−5.5%10-K
FY2018144.7M+1.4%10-K
FY2017142.8M+10.3%10-K
FY2016129.5M+1.1%10-K
FY2015128.2M+1.9%10-K
FY2014125.7M+9.8%10-K
FY2013114.5M+1.6%10-K
FY2012112.7M+8.4%10-K
FY2011104.0M+3.4%10-K
FY2010100.6M—10-K

What is shares outstanding?

Shares outstanding is the total number of common shares currently held by all shareholders, including restricted shares.

What is Halozyme Therapeutics's current shares outstanding?

Halozyme Therapeutics (HALO) annual shares outstanding for 2025 was 117.8M, a 4.35% decline from 2024. Halozyme Therapeutics shares outstanding for the quarter ending September 30, 2026 was 113.9M.

What was Halozyme Therapeutics's shares outstanding in 2024?

Halozyme Therapeutics annual shares outstanding for 2024 was 123.1M, a 2.87% decline from 2023.

What was Halozyme Therapeutics's shares outstanding in 2023?

Halozyme Therapeutics annual shares outstanding for 2023 was 126.8M, a 6.20% decline from 2022.

What is Halozyme Therapeutics's 5-year shares outstanding CAGR?

Halozyme Therapeutics shares outstanding grew at a compound annual growth rate (CAGR) of 2.70% from FY2020 to FY2025, going from 135.0M to 117.8M over 5 years.

Company
Halozyme Therapeutics
Ticker
HALO
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)